Filing Details
- Accession Number:
- 0000899866-20-000065
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-09 17:05:33
- Reporting Period:
- 2020-06-08
- Accepted Time:
- 2020-06-09 17:05:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc. | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1708764 | Lall Indrani Franchini | C/O Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston MA 02210 | Evp, Chief Compliance Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-06-08 | 1,403 | $114.61 | 35,071 | No | 4 | F | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-06-08 | 5,420 | $114.61 | 29,651 | No | 4 | S | Direct | |
| Common Stock, Par Value $.0001 Per Share | Disposition | 2020-06-08 | 1,433 | $115.00 | 28,218 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
Billionaire Hedge Funds
